TNF and juvenile idiopathic arthritis: As shown in Table 1, drugs that target TNF and its receptor are approved and used in a wide variety of diseases including RA, juvenile idiopathic arthritis (JIA), AS, axial spondyloarthritis (SpA), PS, psoriatic arthritis (PsA), IBD, and Behcet’s disease (BD).